Free tool
FAERS Monitor: Daybue Stix
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 219884 or its brand name (Daybue Stix, Trofinetide). Reports on generic versions are filed under their own applications.
Reports
655
Serious
189
29% of reports
Hospitalization
78
Death reported
8
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea382
- underdose125
- vomiting105
- seizure78
- constipation76
- product use complaint64
- intentional dose omission54
- flatulence48
- weight decreased41
- abdominal discomfort39
- weight increased38
- inappropriate schedule of product administration36
- condition aggravated34
- decreased appetite33
- expulsion of medication29
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 5 |
| 2025 | 18 |
| 2026 | 628 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,504 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| expulsion of medicationSignal | 29 | 1864.3 | 1292.3 | 49,301 |
| product use complaintSignal | 64 | 131.0 | 103.7 | 8,099 |
| intentional dose omissionSignal | 54 | 60.9 | 47.2 | 3,122 |
| underdoseSignal | 125 | 55.1 | 47.0 | 6,595 |
| flatulenceSignal | 48 | 27.2 | 20.7 | 1,188 |
| seizureSignal | 78 | 21.7 | 17.6 | 1,527 |
| diarrhoeaSignal | 382 | 19.0 | 17.8 | 6,703 |
| constipationSignal | 76 | 11.2 | 9.1 | 702 |
| abdominal discomfortSignal | 39 | 7.5 | 5.5 | 214 |
| vomitingSignal | 105 | 7.2 | 6.0 | 564 |
| inappropriate schedule of product administrationSignal | 36 | 6.4 | 4.7 | 161 |
| weight increasedSignal | 38 | 5.4 | 4.0 | 135 |
| weight decreasedSignal | 41 | 4.7 | 3.5 | 118 |
| decreased appetiteSignal | 33 | 4.6 | 3.3 | 89 |
| condition aggravatedSignal | 34 | 3.6 | 2.6 | 62 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.